What insurance companies look for: Common prior authorization criteria include documented BMI meeting the FDA-approved threshold, documentation of weight-related comorbidities (for patients with BMI 27 to 29.9), evidence of previous weight loss attempts (diet, exercise, behavioral modification), a letter of medical necessity from your provider, and sometimes documentation that you have tried and failed other weight loss medications first (step therapy)
Store lyophilized peptide at -20C long-term or 2-8C short-term
The Noom program has comprehensive data on patient health, injection dates, side effects, and weight-loss speed, and we bring that data to bear to personalize the dosing to maximize outcomes and adherence not just to the medication, but to our Noom microhabits program. While many eligible GLP-1 users are deterred from starting medication due to fear of incurring side effects, others are challenged by high medication costs
Start your intake GLP-1 Medications and Inositol: Distinct Mechanisms and Overlapping Goals Semaglutide (Ozempic) activates GLP-1 receptors throughout the body, increasing insulin secretion, slowing gastric emptying, and signaling satiety to the central nervous system